Prittle Prattle Pr

Tag: endometriosis treatment in India

  • Transforming to Precision Robotics: Apollo, Fortis & Nanavati Max Lead a New Era in Women’s Healthcare

    With robotic-assisted surgery redefining women’s health, leading experts Dr. Rooma Sinha, Dr. Swapna Misra & Dr. Uddhavraj Dudhedia urge early adoption to tackle gynaecological disorders

    Gynaecological disorders are on the rise in India, with conditions such as fibroids, ovarian cysts, endometriosis, and gynaecological cancers becoming increasingly prevalent. Healthcare experts stress the need for advanced surgical solutions, such as robotic-assisted surgery, to ensure better patient outcomes with reduced recovery times and minimal discomfort.

    The Silent Crisis: The Growing Burden of Gynaecological Disorders in India
    Women’s health has long been an overlooked area in mainstream healthcare discussions, but the alarming rise in gynaecological disorders has made it an urgent priority. Conditions such as fibroids, endometriosis, benign tumors, and ovarian and endometrial cancers are increasingly being diagnosed, affecting women’s quality of life. However, due to social stigma and fear of traditional surgical complications, many hesitate to seek timely intervention.

    According to Dr. Rooma Sinha, Founder & President of Gynaecological Robotic Surgeons and Chief of Gynaecology at Apollo Hospital Jubilee Hills, Hyderabad, precision medicine is the key to changing this reality.

    “Women already suffer from late menopause, irregular cycles, high-dose hormone therapies for infertility, metabolic disorders, and now ovarian and endometrial tumors. If they also have to endure the trauma of traditional surgery, it is unfair. But with robotic-assisted surgery, we can ensure minimal scarring, reduced pain, and faster recovery. With the da Vinci surgical system, patients are often discharged within 24 hours, and some even within 8-10 hours post-surgery.”

    Robotic-Assisted Surgery: A Paradigm Shift in Women’s Healthcare
    Minimally invasive surgery, powered by robotics and artificial intelligence, has drastically transformed surgical outcomes. With precision, enhanced visualization, and improved dexterity, robotic-assisted techniques have revolutionized oncology, particularly in women’s cancers.

    Dr. Swapna Misra, a certified International Robotic Gynaecological Surgeon at Fortis Hospital Mohali, highlights the urgent need for awareness:
    “The rising burden of endometrial and ovarian cancer is a pressing health crisis. The modern lifestyle, marked by chronic stress, obesity, and hormonal imbalances, is now affecting younger women, with diagnoses occurring as early as 25-35 years. Early screenings, combined with advanced robotic surgery, can significantly improve survival rates.”

    Overcoming Fear & Misinformation: Need for Better Awareness
    Despite medical advancements, lack of awareness and misconceptions about new technologies remain major barriers to care.

    Dr. Uddhavraj Dudhedia, Gynaecological Robotic Oncosurgeon at Nanavati Max Super Speciality Hospital, Mumbai, stresses the need to bridge this gap:
    “Many women hesitate to seek treatment due to fear of traditional surgery disrupting their lives. The absence of awareness about robotic-assisted surgery leads to delayed decision-making and prolonged suffering. From a comparative standpoint, I have observed that minimally invasive procedures using advanced technologies like da Vinci robotics reduce pain by 30-40% compared to conventional surgery. This not only enhances patient comfort but also improves overall recovery rates.”

    Beyond Oncology: The Future of Women’s Health & Robotics
    The application of robotics in gynaecology is not limited to oncology. It is increasingly being used in cases such as hysterectomies, myomectomies (removal of fibroids), and complex pelvic reconstructive surgeries.

    Dr. Devika Gunasheela, Founder of Tattvagene & Gunasheela Hospital, emphasizes how genetic testing and AI-driven reproductive healthcare are transforming fertility treatments:
    “Infertility is not just a medical condition but an emotional and societal challenge. Many women face stigma when they struggle with conception. Genetic screening and AI-driven fertility treatments are transforming reproductive healthcare, improving pregnancy outcomes.”

    Similarly, Dr. Sulochana Gunasheela, who pioneered IVF treatments in India, notes:
    “Decades ago, when we introduced IVF, people were skeptical. Today, we integrate genetic testing and AI-based embryo selection to improve success rates and reduce emotional stress for aspiring mothers.”

    The Intersection of Women’s Health & Workplace Policies
    Beyond clinical advancements, women’s health must be integrated into corporate policies to ensure well-being across different life stages. Dr. Kavita Bhardwaj, Head of Exploration at Hindustan Zinc, believes:

    “Women’s healthcare goes beyond maternal care. Workplace policies must address menstrual health, fertility treatments, and menopause to ensure that women do not have to choose between their careers and their health.”

    Healthcare Accessibility for Working Women & Entrepreneurs
    Maternity care and preventive screenings remain critical gaps for women entrepreneurs and working professionals. Madhura DasGupta Sinha, Founder & CEO of Aspire for Her, emphasizes:

    “80% of women entrepreneurs struggle with healthcare access while managing businesses. We must build an ecosystem that supports working women with better insurance, maternity benefits, and preventive screenings.”

    Similarly, Saibal Biswas, SVP at MediBuddy, highlights how digital healthcare can fill these gaps: “MediBuddy’s #HerHealthBuddy campaign tackles period stigma, reproductive health myths, and the gender gap in medical research. Women’s health must be prioritized year-round, not just on Women’s Day.”

    Final Take: Prioritizing Women’s Healthcare Beyond a Single Day
    The advancement of robotic-assisted surgery, the integration of AI in fertility treatments, and the push for corporate healthcare policies reflect a new era for women’s health. The conversation must extend beyond Women’s Day to become an integral part of policy-making, workplace benefits, and medical research.
    With Apollo, Fortis, and Nanavati Max leading the charge, it’s time to accelerate early detection, advanced surgical options, and equal access to healthcare for women across all walks of life.
    At Prittle Prattle News, featuring you virtuously, we celebrate the commitment and innovation. Led by Editor-in-Chief Smruti Bhalerao, our platform is dedicated to sharing impactful stories that inspire change and create awareness. Follow us on LinkedIn, Instagram, and YouTube for more stories that matter.

  • Kokilaben Hospital Becomes India’s First European-Certified Endometriosis Center, Revolutionizing Women’s Healthcare

    Bridging India’s Healthcare Gap with Global-Standard Endometriosis Treatment

    Endometriosis, a painful and often misdiagnosed condition, affects 10-15% of Indian women, yet many go years without proper diagnosis or treatment. Women struggling with severe pelvic pain, menstrual disorders, and unexplained infertility often face fragmented care, outdated treatments, and limited access to minimally invasive surgeries. Despite affecting 247 million women globally, endometriosis remains one of the least understood conditions in India’s healthcare system.
    For the first time in India, a dedicated multidisciplinary center is changing this reality. Kokilaben Dhirubhai Ambani Hospital (KDAH) has become the first and only hospital in India to receive the EuroEndoCert certification from the European Endometriosis League. This prestigious accreditation, previously awarded only to leading hospitals in Europe and the U.S., validates KDAH’s world-class treatment model, setting a new benchmark for women’s healthcare in India.
    This recognition is not just an award: it is a transformational shift in how endometriosis is treated in India. The certification ensures that KDAH follows the same advanced diagnostic and treatment protocols as those used in Germany, France, and the United Kingdom. Patients now have access to gold-standard treatments, including robotic-assisted laparoscopic surgery, specialized pain management, and fertility-preserving interventions.

    Why India Needed a Global-Standard Endometriosis Center
    Unlike in Germany and Australia, where endometriosis is widely recognized and treated early, India has no standardized treatment guidelines, leading to delayed diagnosis and poor patient outcomes. Studies suggest that Indian women often wait over a decade before being correctly diagnosed, compared to the global average of 7-10 years.
    A report by the World Health Organization (WHO) confirms that 50% of women with endometriosis experience infertility, yet India lacks a coordinated approach to managing both conditions together. Unlike hospitals in the U.S. and the U.K., which integrate gynecology, pain management, and reproductive medicine, most Indian hospitals focus only on surgery, leaving patients without long-term disease management solutions.
    KDAH’s certified Endometriosis Clinic changes this model entirely by offering a comprehensive, patient-first approach. It brings together gynecologists, radiologists, pain specialists, colorectal surgeons, and fertility experts: ensuring that women receive holistic, research-backed treatment rather than temporary symptom relief.

    A Step Forward for Indian Women’s Health & Infertility Treatment
    The impact of endometriosis on fertility remains one of its most devastating consequences. Research shows that 40-50% of women diagnosed with the condition struggle to conceive, as scar tissue, inflammation, and hormonal imbalances affect the ovaries and fallopian tubes. Many women only discover they have endometriosis when they face difficulties getting pregnant.
    Kokilaben Hospital is tackling this issue head-on by integrating advanced fertility treatments into its endometriosis care model. This includes:

    • Specialized laparoscopic and robotic-assisted surgeries designed to remove lesions without damaging ovarian reserves.
    • Personalized hormonal therapy protocols that help preserve egg quality while managing symptoms.
    • Dedicated fertility counseling and ART (Assisted Reproductive Technologies), including In Vitro Fertilization (IVF) and Intrauterine Insemination (IUI) for endometriosis patients.

    By adopting these evidence-based protocols, KDAH ensures that women suffering from endometriosis receive both effective pain management and fertility support, helping them build families without unnecessary delays.

    How KDAH’s EuroEndoCert Recognition Transforms Women’s Healthcare in India
    Before this certification, endometriosis treatment in India was inconsistent, with most hospitals relying on outdated techniques. The introduction of EuroEndoCert standards now places KDAH on par with the world’s top endometriosis treatment centers in France and Sweden.
    The certification confirms that KDAH is following:

    • European-standard diagnostic guidelines, reducing misdiagnosis rates.
    • Minimally invasive robotic and laparoscopic surgeries, leading to faster recovery and reduced recurrence rates.
    • Pain management strategies that go beyond surgery, incorporating nerve-block therapies and neuromodulation techniques.
    • Comprehensive patient education and awareness initiatives, ensuring that women seek treatment earlier rather than waiting years for a diagnosis.

    A Landmark Moment for Women’s Healthcare Policy in India
    Beyond transforming patient care, this certification has broader policy implications for India’s healthcare system. Currently, India spends less than $5 million annually on endometriosis research, compared to $120 million in the U.S. and $78 million in Australia.
    KDAH’s leadership in this field could drive national-level changes, including:

    • Implementation of endometriosis screening programs in hospitals across India.
    • Inclusion of endometriosis in national health policies, similar to the UK’s Endometriosis Action Plan.
    • More government funding for research, leading to better treatment accessibility for all Indian women.
    A Message from the Experts
    Dr. Anshumala Shukla-Kulkarni, Head of Minimally Invasive Gynecology & Robotic Surgery at KDAH, highlights the urgency of this advancement:
    – This certification validates our mission to transform endometriosis care in India. No woman should suffer in silence or wait years for an accurate diagnosis. Our multidisciplinary approach ensures that patients receive cutting-edge treatment, pain management, and fertility support: all in one place.- 
    Dr. Santosh Shetty, CEO & Executive Director of KDAH, emphasizes the larger impact:
    – This is a historic moment, not just for our hospital but for India’s entire healthcare system. We hope this recognition encourages other hospitals to adopt a more holistic, research-driven approach to women’s health.- 
    Conclusion: A Game-Changer for Indian Women’s Health
    KDAH’s EuroEndoCert certification marks a turning point for endometriosis treatment in India. By aligning with global best practices, the hospital is setting a new standard for patient care, bridging the gap between Indian healthcare and world-class medical advancements.
    For the millions of Indian women suffering in silence, this is more than just a certification: it’s a lifeline to better health, improved fertility outcomes, and a future free from chronic pain.
    At Prittle Prattle News, featuring you virtuously, we celebrate commitment and innovation. Led by Editor-in-Chief Smruti Bhalerao, our platform is dedicated to sharing impactful stories that inspire change and create awareness. Follow us on LinkedIn, Instagram, and YouTube for more stories that matter.